Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $40.1000 (-1.96%) ($37.1000 - $40.5000) on Thu. Sep. 8, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.98% (three month average) | RSI | 57 | Latest Price | $40.1000(-1.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 3.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(8%) SKYY(8%) ARKK(7%) EWG(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.49% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-5%) SLV(-4%) GDX(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.49% (StdDev 4.98%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $38.58(3.94%) | 10 Day Moving Average | $36.95(8.53%) | 20 Day Moving Average | $36.55(9.71%) | To recent high | -15.6% | To recent low | 24.9% | Market Cap | $790m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |